ACQUISITIONS (Narrative) (Details) shares in Thousands, $ in Thousands, $ in Thousands |
Oct. 09, 2023
USD ($)
shares
|
Oct. 09, 2023
AUD ($)
shares
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Oct. 09, 2023
AUD ($)
|
|---|---|---|---|---|---|
| Business Acquisition [Line Items] | |||||
| Estimated value of contingent consideration | $ 129 | ||||
| Goodwill | $ 38,834 | $ 39,320 | |||
| TRED | |||||
| Business Acquisition [Line Items] | |||||
| Acquisition purchase price | $ 6,849 | $ 10,741 | |||
| Cash paid | $ 5,659 | $ 8,875 | |||
| Number of shares issued | shares | 179 | 179 | |||
| Value of shares issued | $ 1,069 | ||||
| Estimated value of contingent consideration | 638 | $ 1,000 | |||
| Contingent consideration, fair value | 121 | $ 189 | |||
| Goodwill | $ 2,832 |
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|